WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Website Related Online Marketing Monday, August 20, 2018 
Add Press Release News | News Feeds Feeds | Email This News Email


Global CNS Therapeutics Market 2018-2022: Increased Adoption of New-Generation Drugs
Thursday, June 14, 2018

DUBLIN, June 14, 2018 /PRNewswire/ --

The "Global CNS Therapeutics Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The Global CNS therapeutics market to grow at a CAGR of 4.36% during the period 2018-2022.

Global CNS Therapeutics Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. CNS therapeutics cater to CNS disorders that affect the structure or function of the brain or spinal cord such as Parkinson's disease, epilepsy, Alzheimer's disease, anxiety, depression, and bipolar disorders. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. To calculate the market size, the report considers the revenue generated from the sales of therapeutics for CNS disorders.

The increased adoption of new-generation drugs will be a key trend for the market growth. First-generation and second-generation drugs have many side-effects, limited therapeutic range, and complicated pharmacokinetics. Third-generation drugs have longer therapeutic ranges and limited side effects in comparison to the second-generation drugs, driving the adoption of third-generation drugs.

According to the report, the increasing prevalence of mental illness will drive the market growth. Mental disorders coexist with diseases such as diabetes, cardiovascular disease, or obesity. The increased disease burden and mental disorders requires the availability of effective therapeutics for mental health to decrease the number of deaths caused due to mental illness.

Further, the report states that the side effects of CNS therapeutics will impact the market growth. Therapeutics for CNS disorders have numerous risks and side-effects such as drowsiness and weight gain, insomnia, lowered libido, tremors, and agitation. Also, anti-epilepsy medications result in periodic mood swings that are consequent in depression and anxiety.

Market Trends

    --  Increasing awareness programs
    --  Increased adoption of new-generation drugs

    --  Advances in technology in treating mental disorders

Key vendors

    --  Eli Lilly
    --  F. Hoffmann-La Roche
    --  Johnson & Johnson
    --  Merck
    --  Novartis

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Market Landscape

Part 05: Market Sizing

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Market Segmentation By End-User

Part 09: Regional Landscape

Part 10: Decision Framework

Part 11: Drivers And Challenges

Part 12: Market Trends

Part 13: Vendor Landscape

Part 14: Vendor Analysis

Part 15: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/dxkghf/global_cns?w=5

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-cns-therapeutics-market-2018-2022-increased-adoption-of-new-generation-drugs-300665741.html

SOURCE Research and Markets



Email This News Email | Submit To Slashdot Slashdot | Submit To Digg.com Digg | Submit To del.icio.us Del.icio.us | News Feeds Feeds

RELATED NEWS ARTICLES
Nav Comparative SWOT & Strategy Focus of Europe's Top 6 Medium & Heavy Truck Manufacturers - Daimler, Volvo, MAN, Scania, DAF, Iveco | Aug 20, 2018
Nav JustForex Offers New Payment Methods | Aug 20, 2018
Nav Global Soil Aerators Market 2018-2022 - Key Vendors are Alstrong, Deere & Company, Great Plains Manufacturing, Husqvarna Group & Schiller Grounds Care | Aug 20, 2018
Nav Spatialitics names Dan Exley SVP & Chief Client Officer | Aug 20, 2018
Nav 33 Mile Radius Launches New Call Tracking System For Disaster Mitigation, Restoration, And Home Services Contractors | Aug 20, 2018
Nav Global Business Jet Market 2018-2026 - High Fliers are Bombardier, Dassault Aviation, Embraer, Gulfstream Aerospace Corporation & Textron Aviation | Aug 20, 2018
Nav Cool Holdings, Inc. Announces Acquisition of Apple Boutique Store Retail Chain in the Dominican Republic | Aug 20, 2018
Nav North America Class 6-8 Truck Manufacturers Market 2018-2023: Comparative SWOT & Strategy Focus of the Top Players - Daimler, Volvo, PACCAR, Navistar | Aug 20, 2018
Nav ChineseInvestors.com, Inc.'s Wholly Owned Foreign Enterprise, CBD Biotechnology Co Ltd., Launches Innovative CBD Two-tier Direct Selling Initiative to Accelerate Sales in China | Aug 20, 2018
Nav Evoke Group Simplifies Structure, Unveils New Identity and Vision | Aug 20, 2018
NEWS SEARCH

FEATURED NEWS | POPULAR NEWS
Submit News | View More News View More News